IL163886A0 - Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune,anti-inflammatory, anti-tumor and dna repair proc esses of warm blooded animals - Google Patents

Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune,anti-inflammatory, anti-tumor and dna repair proc esses of warm blooded animals

Info

Publication number
IL163886A0
IL163886A0 IL16388603A IL16388603A IL163886A0 IL 163886 A0 IL163886 A0 IL 163886A0 IL 16388603 A IL16388603 A IL 16388603A IL 16388603 A IL16388603 A IL 16388603A IL 163886 A0 IL163886 A0 IL 163886A0
Authority
IL
Israel
Prior art keywords
tumor
inflammatory
isolation
purification
water soluble
Prior art date
Application number
IL16388603A
Other languages
English (en)
Original Assignee
Pero Ronald W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27788020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL163886(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pero Ronald W filed Critical Pero Ronald W
Publication of IL163886A0 publication Critical patent/IL163886A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL16388603A 2002-03-07 2003-03-07 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune,anti-inflammatory, anti-tumor and dna repair proc esses of warm blooded animals IL163886A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/093,794 US6964784B2 (en) 2002-03-07 2002-03-07 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
PCT/IB2003/000824 WO2003074062A2 (en) 2002-03-07 2003-03-07 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals

Publications (1)

Publication Number Publication Date
IL163886A0 true IL163886A0 (en) 2005-12-18

Family

ID=27788020

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16388603A IL163886A0 (en) 2002-03-07 2003-03-07 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune,anti-inflammatory, anti-tumor and dna repair proc esses of warm blooded animals

Country Status (11)

Country Link
US (7) US6964784B2 (OSRAM)
EP (1) EP1485114A2 (OSRAM)
JP (1) JP2005526053A (OSRAM)
KR (1) KR20040099300A (OSRAM)
CN (1) CN1649610A (OSRAM)
AU (1) AU2003207894A1 (OSRAM)
BR (1) BRPI0308253A2 (OSRAM)
CA (1) CA2477785A1 (OSRAM)
IL (1) IL163886A0 (OSRAM)
MX (1) MXPA04008567A (OSRAM)
WO (1) WO2003074062A2 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042429A2 (en) * 2000-11-03 2002-05-30 Proteotech, Inc. Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
EP1631304A4 (en) 2003-04-04 2007-03-21 Unigen Pharmaceuticals Inc FORMULATION OF DUAL CYCLOXYGENASE (COX) AND LIPOXYGENASE (LOX) INHIBITORS FOR THE SKIN CARE OF MAMMALS
WO2005094773A1 (es) † 2004-04-01 2005-10-13 Industrial Farmaceutica Cantabria, S.A. Composiciones fotoprotectoras y/o fotoinmunoprotectoras de la piel y sus usos
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
US20050287227A1 (en) * 2004-04-16 2005-12-29 Ronald Pero Supplement containing carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and method of the same
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
MX2007011200A (es) * 2005-03-16 2008-04-02 Ronald W Pero Composiciones medicinales de sales, quelatos y/o acidos libres de acidos organicos de alfa-hidroxilo y procesos y metodos relacionados.
US20090035395A1 (en) * 2007-08-01 2009-02-05 Peter Koepke Spondias mombin l. extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
JP5660898B2 (ja) * 2007-11-09 2015-01-28 ユニバーシティ オブ テネシー リサーチ ファウンデーション 経口投与用の抗炎症性キナ酸誘導体
EP2370086A2 (en) * 2008-12-01 2011-10-05 Lifespan Extension Llc Methods and compositions for altering health, wellbeing, and lifespan
US8911774B2 (en) * 2009-05-18 2014-12-16 Cellhealth Technologies Ltd. Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
US9457009B2 (en) 2012-05-31 2016-10-04 The United States Of America As Represented By The Department Of Veterans Affairs Methods and compositions for preventing and treating auditory dysfunctions
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
AU2016227767A1 (en) * 2015-03-03 2017-07-27 Société des Produits Nestlé S.A. Compound use in promoting energy expenditure
US10098922B1 (en) 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell
CN113759067A (zh) * 2021-08-06 2021-12-07 北京康仁堂药业有限公司 一种薄层色谱的构建方法和鉴定方法及其应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE538512A (OSRAM) * 1954-05-28
DE1905875A1 (de) * 1969-02-06 1970-08-20 Stark Dr Hans C Mittel,hergestellt durch die Kombination verschiedener chemischer Koerper,das die Regulierung und vorzeitige Hervorrufung der Periodenblutung bewirkt sowie im Klimakterium die Menstruation nach dem Stillstand wieder hervorruft und fuer mehrere Jahre verlaengert
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US4940803A (en) * 1988-05-23 1990-07-10 Merck & Co., Inc. Process for synthesis of 1R,2R,5R-2-hydroxy-6-oxo-7-oxabicyclo[3.2.1]-octane
DE69228542T2 (de) * 1992-08-03 1999-07-29 Societe Des Produits Nestle S.A., Vevey 3- und/oder 4-substituierte Chinasäurederivate und Verfahren zur Herstellung von 3- und/oder 4-substituierten Chinasäurederivaten
US5952375A (en) * 1995-02-27 1999-09-14 Gilead Sciences, Inc. Compounds and methods for synthesis and therapy
US6238675B1 (en) * 1997-02-27 2001-05-29 Campamed Corp. Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals
US6039949A (en) * 1997-02-27 2000-03-21 Campamed, Inc. Method of preparation and composition of a water soluble extract of the plant species uncaria
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
JPH11245503A (ja) * 1998-03-02 1999-09-14 Bando Chem Ind Ltd 水性インク吸収材及び該吸収材の層を有する積層フィルム
PT1176195E (pt) * 1999-04-09 2013-07-18 Kyowa Hakko Kirin Co Ltd Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
US6723368B1 (en) * 1999-12-21 2004-04-20 Loretta M. Zapp Method for enhancing post-processing content of beneficial compounds in beverages naturally containing same
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
US6410246B1 (en) * 2000-06-23 2002-06-25 Genetastix Corporation Highly diverse library of yeast expression vectors
US7863020B2 (en) * 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
US20060034830A1 (en) * 2000-06-28 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
US7449308B2 (en) * 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
US7625756B2 (en) * 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US20060029604A1 (en) * 2000-06-28 2006-02-09 Gerngross Tillman U Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
US20060034828A1 (en) * 2000-06-28 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
US7795002B2 (en) * 2000-06-28 2010-09-14 Glycofi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US20060024304A1 (en) * 2000-06-28 2006-02-02 Gerngross Tillman U Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
ATE440959T1 (de) * 2000-06-28 2009-09-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine
GB0108903D0 (en) * 2000-10-05 2001-05-30 Aventis Pharm Prod Inc Novel crystalline forms of a factor Xa inhibitor
US7064191B2 (en) * 2000-10-06 2006-06-20 Kyowa Hakko Kogyo Co., Ltd. Process for purifying antibody
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
CA2347879A1 (en) * 2001-05-11 2002-11-11 Vanderbilt University Substituted dicinnamoylquinides and their use in augmentation of adenosine function
EP2359685B1 (en) * 2001-12-27 2013-12-04 GlycoFi, Inc. Methods to engineer mammalian-type carbohydrate structures
US20060034829A1 (en) * 2001-12-27 2006-02-16 Gerngross Tillman U Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
US20060024292A1 (en) * 2001-12-27 2006-02-02 Gerngross Tillman U Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
CA2551484C (en) * 2003-12-24 2015-03-31 Glycofi, Inc. Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
WO2005090552A2 (en) * 2004-03-17 2005-09-29 Glycofi, Inc. Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
CN101084233B (zh) * 2004-04-29 2012-08-15 格利科菲公司 用于在糖蛋白产生中减少或消除α-甘露糖苷酶抗性聚糖的方法

Also Published As

Publication number Publication date
KR20040099300A (ko) 2004-11-26
CA2477785A1 (en) 2003-09-12
US20110245337A1 (en) 2011-10-06
US8372449B2 (en) 2013-02-12
WO2003074062A2 (en) 2003-09-12
US20050176825A1 (en) 2005-08-11
AU2003207894A1 (en) 2003-09-16
US7947312B2 (en) 2011-05-24
BRPI0308253A2 (pt) 2016-07-12
US20090298939A1 (en) 2009-12-03
US6964784B2 (en) 2005-11-15
US20110263706A1 (en) 2011-10-27
US20060068035A1 (en) 2006-03-30
JP2005526053A (ja) 2005-09-02
MXPA04008567A (es) 2004-12-06
US7595064B2 (en) 2009-09-29
US7955626B2 (en) 2011-06-07
EP1485114A2 (en) 2004-12-15
US8372448B2 (en) 2013-02-12
WO2003074062A3 (en) 2004-02-05
CN1649610A (zh) 2005-08-03
US7579023B2 (en) 2009-08-25
US20090281180A1 (en) 2009-11-12
US20030170320A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
BRPI0308253A2 (pt) isolamento, purificação e identificação estrutural de um componente bioativo de um extrato solúvel em água de uma espécie botânica para realçar processos imunes, antiinflamatórios, antitumor e de reparo de dna de animais de sangue quente
AU2002253774A1 (en) Pressurized hot water extraction
ATA17052002A (de) Bauteil zur wärmeableitung
EP2216609A4 (en) HOT WATER SUPPLY SYSTEM
AU2003256110A1 (en) Heat exchange unit including apparatus to remove condensed water
GB2392816B (en) Hot water soluble instant tea
IL166386A0 (en) Method for enhancing the nutritive value of plant extract
AU2003285045A8 (en) Heat transfer system
HK1072185A (en) Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
EP1495670A4 (en) PLANT TRANSFORMATION SYSTEM
DE502004007837D1 (de) Hochglänzende nichttoxische perlglanzpigmentpräparation
PT1592837E (pt) Produtos de condensação de aldeído que não amarelecem
ATE365783T1 (de) Wasserlöslicher schmelzklebstoff
AU2003221110A1 (en) Mucosal immune vaccine for periodontal diseases
AU2003216267A8 (en) Plant preparations
ZA200801973B (en) Solar heated hot water system
BR0207619B1 (pt) sistema de retificação integrado a quente avançado.
SI1565408T1 (sl) Postopek in naprava za desalinizacijo vode, ki vsebuje sol
DK1581195T3 (da) Filmovertrukkede tabletter omfattende et ekstrakt af røde vinblade
AU2003267841A1 (en) Highly bioactive and productive chicken embryo extract and method for preparation thereof
DE602004012104D1 (de) Pflanzenextraktionsverfahren und extrakt
GB2425477B (en) Extract of Scutellaria for the treatment of RSV
DE10224129B8 (de) Wärmebehandlungsanlage
GB2411357B (en) Vaccine for cold-water disease in fish
ITNA20020064A1 (it) PROCEDIMENTO, TECNICA E METODO PER L'OTTENIMENTO DI UN TIPO DI MOSAICO IN LEGNO APPLICATO AD OGGETTI IN LEGNO ED OGGETTI IN LEGNO COSl OTTENUTI.